Drugs & Targets Oncopeptides to submit NDA for melflufen in multiple myeloma May 24, 2019Vol.45 No.21
Clinical Roundup NRG Oncology phase III study results: partial breast irradiation is effective May 24, 2019Vol.45 No.21
Clinical Roundup First states to expand Medicaid saw larger screening rate increases May 24, 2019Vol.45 No.21
Funding Opportunities Astellas Oncology calls for entries to C3 Prize to award $200,000 May 24, 2019Vol.45 No.21
In Brief Singh named sub-PI Heartland Cancer Research NCORP Executive Committee May 24, 2019Vol.45 No.21
Dana-Farber wins legal dispute over PD-1/PD-L1 patents; BMS set to lose exclusive license May 24, 2019Vol.45 No.21By Paul Goldberg
